Boehringer Ingelheim Pharmaceuticals Inc. and BioImage AS sign licensing deal on Redistribution® Technology

04-Feb-2005

BioImage A/S announced that it has signed a licensing agreement with Boehringer Ingelheim Pharmaceuticals Inc., granting it the freedom to use BioImage's Redistribution® technology in its drug discovery research. Financial terms were not disclosed.

The Redistribution® patent portfolio covers a broad range of methods aimed at studying intracellular signalling events. The Redistribution® technology enables high throughput screening on a number of drug discovery live cell screening applications, such as protein translocations, receptor internalizations, protein trafficking, secretions, etc. BioImage is presently out licensing the portfolio to a number of leading companies within the life science industry.

Other news from the department research and development

Most read news

More news from our other portals

So close that even
molecules turn red...